Each step sends waves of agony from your toes straight up your leg.
Even the short trip from your bed to the bathroom feels like you’re walking a mile on broken glass.
Gout is painful. It makes life miserable. But at least it won’t kill you.
And any drug used to treat it ought to be able to make that same promise.
But a new gout drug called lesinurad may be the most dangerous Big Pharma has ever tried to force on gout patients. It can attack your heart and your kidneys — and maybe even shave years off your life.
And thanks to one of the most shocking votes in FDA history, it may be headed soon to a prescription pad near you.
If the FDA unleashes AstraZeneca’s lesinurad (it’ll be sold under the brand name Zurampic) on millions of Americans with gout, it may all be because of one measly vote.
You see, an FDA advisory panel recently recommended that the agency approve lesinurad — and that’s scandalous enough.
But when the panelists had to vote on whether lesinurad was safe — and whether its benefits outweighed the risks — it squeaked by with a 7-6 vote.
And one of the panel members decided not to vote at all.
But the fact that even seven of these so-called drug experts could think lesinurad was OK for you to use makes this whole vote feel more rigged than a Third World election.
Let me explain. When AstraZeneca first started testing lesinurad, it used a 200 mg dose. But that wasn’t enough to get the job done.
People in the study were still experiencing gout flare-ups and were developing those painful, needle-like uric acid crystals.
So the company increased the dose to 400 mg — and that’s when the problems really started. I’m talking about heart problems, major kidney issues and even an increased chance of death.
Death? To treat gout? No thanks!
So AstraZeneca and the FDA are leaving gout sufferers with two options. Take a lower dose, which may not work — or double up on your pills and play Russian roulette with your life.
That’s some choice, huh?
Believe it or not, one panel member even said that if lesinurad turns out to be too dangerous (you know, after millions of us have been used as lab rats) the FDA can just “take it off the market later.”
Are you kidding me? What rock has this guy been living under? You know by now that there’s a better chance of finding Bigfoot riding a unicorn than seeing the FDA pull an approved drug off the shelves.
And trust me — lesinurad is headed for approval at warp speed.
The recommendations of expert panels are almost always rubber-stamped by the FDA, so you can pretty much bet the farm that lesinurad will soon get the agency nod. And that, of course, will be followed by a loud chorus of bells and whistles from the AstraZeneca hype machine.
And that’s why you need to be on guard. Lesinurad will be touted as “the first selective uric acid reabsorption inhibitor” available in the U.S.
There are going to be lots of doctors just itching to try it — and that puts every gout patient in America right in the crosshairs.
The good news is that there are plenty of natural — and proven — remedies that can help keep those gout attacks in check. They may not come with that worthless FDA stamp of approval — but they won’t damage your heart or kidneys, either.
- Apple cider vinegar has been shown to break up uric acid crystals and help prevent them from reforming in joints. It also can reduce swelling and inflammation and help balance your body’s pH levels. Many gout sufferers have reported relief within hours. The recommended dose is two to three tablespoons in a glass of water up to three times a day.
- Tart cherries (or concentrated tart cherry juice) have a flavonoid called anthocyanin. It’s what gives cherries their red color, and it’s been shown to have an anti-inflammatory, pain-killing effect. If you buy juice, just make sure it doesn’t have any added sugars or artificial sweeteners.
- Water can also help to flush the uric acid out of your system — only be sure it’s pure, nonfluoridated water. And skip the soda and alcohol, which can both promote gout flare-ups.
“FDA panel backs lesinurad (Zurampic) for gout” Troy Brown, RN, October 23, 2015, Medscape, medscape.com